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Summary 
 Vaccination of health care workers (HCWs) against hepatitis (HBV) infection is highly necessary in Nigeria where the 
infection occurs in hperendemic proportions. We hereby determine the trends in the administration of HBV vaccine at 
the University College Hospital (UCH), Ibadan, Nigeria. The study reviewed the records for the administration of 
vaccine against HBV at the Staff Medical Services Department of UCH, Ibadan, Nigeria, from 1994 to 2001. A total of 
1,437 subjects consisting of 686 (47.7%) males and 751 (52.3 %) females were vaccinated against HBV from 1994 to 2001. 
They were aged 16 to 64 years and consisted of 356 students (24.8%) and 1081 healthcare workers (HCWs) (75.2%) 
which comprised Doctors (30.9%), Dentists (1.9%), Paramedics (19.6%), Non-medics (14.6%) and subjects with 
undisclosed occupational category ((10.7%). About 11% to 100% of the subjects had annual prescreening for HBsAg 
sero-negativity from 1996 to 2001 but none had post vaccination assay of anti-HBs titre. All the subjects received 1st 
dose of 0, 1, 2 accelerated HBV vaccination schedule while on annual basis, 16.7% to 91.8% of the subjects received the 
3rd dose of the vaccine. Despite the proportional participation of the different occupational groups was highest among 
the doctors and dentists but lowest among the paramedics, only 59.7% of all the vaccinees had three dose(s) of the 
vaccine during the 8 year period. In conclusion, although the HBV vaccination programme had shortcomings, it is an 
established practice at UCH, Ibadan and efforts should be made to improve on its prevailing standard. 
 




Although, hepatitis B virus (HBV) infection occurs in 
hyperendemic proportions in sub-Saharan Africa 
including Nigeria [1]; the introduction of vaccination 
against the infection has curtailed its chronic sequelae 
in countries where there have been strict and proper 
implementations of the immunization strategy [2]. The 
scheme has also been incorporated into the national 
immunization programme of the different countries 
[3]. Also, protection of at-risk groups such as the health 
care workers (HCWs) is particularly important in order  
 
to reduce the spread of the virus as well as the 
prevalence of its attendant sequalae in the community 
[1, 4].  
The prevalence of HBV infection among Nigerian 
HCWs is high (38.7%) [5]. A high prevalence rate of the 
infection also exists among Nigerian students [6, 7]. 
These reports support the need to vaccinate HCWs 
against HBV especially with use of the recombinant 
DNA technology type of HBV vaccines. The Rapid 
Immunisation Schedule consisting of series of three 
intramuscular injections given at 0, 1, 2 months and 
administration of a booster dose of vaccine at the 12th 
month after the first dose will confer protection against 
HBV infection for further 5 to 8 years when the next 
booster dose will be due [8-10]. Completion rates of the 
vaccination has been reported to be as high as 71% for 
the receipt of 3 or more doses of hepatitis B vaccine 
among HCWs in United States between 2002 and 2003 
[4].  
  The question arises if the programme is being 
pursued in accordance with the international 
recommendation. This has led to our study on the 
determination of the trends in the vaccination of 
HCWs against HBV at the University College Hospital, 
Ibadan (UCH), Nigeria. 
Materials and Methods 
 This retrospective study reviewed the records for the 






Immunization Unit of the Staff Medical Services 
Department, UCH from 1994 to 2001. Data on sex, age, 
occupational distribution of all the vaccinees were 
extracted. Information on the prescreening of the 
vaccinee for Hepatitis B surface antigenaemia (HBsAg) 
and anti-bodies to Hepatitis B core antigen (anti-HBc) 
were also obtained. Similarly, the number of dosages 
of the vaccines received as well as the type of vaccines 
administered, were collected. The study was approved 
by the Joint UCH/UI Ethical Review Board prior to its 
execution. The data obtained were handled with strict 
confidence and expressed in tables and graphs. The 
significance of any hypothesis was investigated using 
appropriate statistical test at 5% probability level. 
Results  
A total of 1,437 of the HCWs at UCH, Ibadan were 
involved in the study and they comprised 686 males 
(47.7%) and 751 females (52.3%) with a sex ratio of1:1.6. 
The HCWs were vaccinated against HBV from 1994 to 
2001, Table 1. Their ages ranged from 16 to 64 years but 
the subjects were below 40 years until 1999 when those 
aged up to 64 years participated in the vaccination 
programme. The year 1999 had the highest 
participation while 1995 had the least. The 
participation in 1994 was twice that of 1995. Thereafter, 
it rose to a peak in 1999 and further declined 
progressively for the subsequent two years. The 
schedule for 1999 was principally carried out by the 
hospital consultants as an effort at immunizing all 
HCWs against HBV. 
Table 2 shows that the subjects consisted of 1081 
HCWs (75.2%) and 356 students (24.8%). Only 1283 
(89.3%) of the HCWs disclosed the type of their 
occupation. The HCWs who received first dose of HBV 
vaccine included doctors comprising Physicians 
(14.1%), Paediatricians (2.7%), Surgeons (3.8%), 
Obstretricians and Gynaecologists (2%), and House 
Officers (8.3%); Dentists (1.9%), Paramedics (Nurses, 
Nursing Assistants, Laboratory Technologists, 
Pharmacists, Radiographers, Medical and Social 
Workers, Physiotherapists, Medical Record Staff, 
Occupational Therapists, Medical Illustration Unit 
Staff) (19.6%) and Non-medics (administrative, 
secretariat, engineering, maintenance   and other 
hospital support staff), 14.6%.  
Prescreening for HBsAg prior to vaccination was not 
carried out for the initial period of two years and was 
commenced in 1996, Table 3. Only 10.5% of the 
participants had prescreening in 1996. The figure rose 
to 70.1% in 1997 and 100% from 1999 to 2001. The 
exercise in 1999 involved prescreening of all workers 
for not only HBsAg but also anti-HBc. All the 
prescreened subjects were HBsAg sero-ngative before 
they administered HBV vaccine. 





1994 20 27.7± 7.2 2(10) 11 9
1995 10 28.7 ± 9.3 1(10) 7 3
1996 38 26. 0± 4.2 0(0) 27 11
1997 41 25.7± 7.7 2(4.9) 23 18
1998 88 23.2 ± 6.7 2(2.3) 34 54
1999 546 49.0 ± 14.3 244(44.7) 275 271
2000 359 25.3 ± 8.5 26(7.2) 134 225
2001 335 25.8  ± 8.5 19(5.7) 175 160
Table 1: Age and annual distribution of healthcare workers 
vaccinated against HBV at UCH, Ibadan, 1994-2001
 Two available types of recombinant vaccines - 
Genevac B (5.3%) and Engerix B (94.7%) were 
administered. Also, three doses of vaccines at 0, 1, and 
2 or 0, 2and 6 months were scheduled per participant 
every year from 1994 to 2001. Although, all the 








































































Dentistry 28 (1.9) 2 2 2 - 1 6 4 11
Paramedics 282 (19.6) - - - 3 5 206 47 21
Non- medicals 174 (12.1) - 1 - - - 164 5 4
Students 356 (24.8) 1 2 - 15 31 36 121 150
Sub-total 1283(89.3) 20 10 37 41 63 527 325 260
No record 154 (10.7) - - 1(2.6) - 25(28.4) 19(3.4) 34(9.5) 75(22.4)
Total 1437(100) 20(1.4) 10(0.7) 38(2.6) 41(2.9) 88(6.1) 546(38) 359(25) 335(23.3)
Table 2:  Departmental distribution of vaccinees and yearly pattern of the 
receipt of the first dose of vaccine against Hepatitis B virus
Parenthesis - percentages
Paramedics - Nurses, Nursing Assistants, Laboratory Technologists, Pharmacists, Radiographers, Medical and Social 
Workers, Physiotherapists, Medical Record Staff, Occupational Therapists, Medical Illustration Unit Staff
Non-medics – Administrative, Secretariat, Engineering, Maintenance and Other hospital support staff
 
  
    
Table 3: Percentage of healthcare workers prescreened for HBV infection 
and their vaccination status at UCH, Ibadan, Nigeria - 1994 to 2001. 












1994 20 0 100 85.0 60.0 NS NS
1995 10 0 100 90.0 60.0 NS NS
1996 38 10.5 100 86.8 34.2 NS 0.0003
1997 41 70.1 100 95.1 56.1 NS 0.02
1998 88 92.0 100 81.8 58.0 NS 0.0004
1999 546 100.0 100 96.2 91.8 NS NS
2000 359 100.0 100 80.2 54.9 0.003 0.0000
2001 335 100.0 100 58.2 16.7 0.0000 0.0000
Total 1437 94.1 100 81.9 59.7 0.0000 0.0000
p1 - between attendances of 1st and 2nd dose    NS – Not significant  p2 – between attendance of 1st and 3rd dose
vaccine with information on the scheduled dates for 
the two subsequent doses, the percentage 
attendances for the second dose were between 80.2% 
to 96.2% for the initial seven years and it dropped to 
58.2% at the 8th year, p<0.05. There were no 
significant differences between the annual 
participations for the first dose and those for the 
second dose of vaccination except in 2000-1, p<0.05 
while the attendances for the third dose was 
significantly lower than those of the 1st dose in all 
the years except in 1994-5 and 1999, Table 3. No 
vaccinee had assay of its post vaccination anti-HBs 
titre. 
 
Only 1437 (35.9%) and 859 (21.5%) subjects had 
received one and three dose(s) of the vaccine 
respectively by 2001 when compared with the 
population of HCWs (4,001) at UCH, Ibadan in that 
same year. Participation in the vaccination 
programme was highest among the doctors and 
lowest among the paramedics even though the 
doctors and the paramedics accounted for less than a 
sixth and about half percentile of the 2001 
population of HCWs respectively at the institution, 












Doctors & Dentists 572 14.3
Non- medics 561 14.0
Total 4001 100
Table 4: Population of the different occupational groups of 
healthcare workers at UCH, Ibadan, Nigeria; 2001.
 
Discussion  
Although vaccination against HBV began in 1984 
first with a plasma-derived vaccine among non-
immune children under the age of 5 years in the 
Gambian villages of Keneba and Manduar, and later 
a recombinant DNA-derived vaccine [11], active 
programme for the vaccination of HCWs against 
HBV commenced at UCH, Ibadan in 1994. This 
study showed that the programme was not only 
commenced but has been sustained and has evolved 
from few numbers of participants at onset to sixty 
fold by the sixth year. It showed a commendable 
effort being made by the hospital at controlling HBV 
infection primarily among the staff and secondarily 
in the community. This is particularly important 
because Nigeria is a hyperendemic zone for the 
infection with high proportions of the consequences 
of the infection present among its population [12]. 
The gender distribution of the participants being 
predominantly males in the initial three years of the 
programme is probably secondary to the presence of 
highest vaccination rate among the doctors who also 
are predominantly males although the cultural belief 
that the health of the man takes precedence over 
those of the other members of the family could not 
be ruled out despite the fact that the utilization of 
health facilities should be without consideration of 
status of any member of the family. The 
improvement in the gender utilization of the service 
is in consonance with increasing education of the 
females since they formed the bulk of HCWs right 
from foundation of the health care institution.       
The general low number of participants in 1994 to 
1997 could be due to poor knowledge about HBV 
among HCWs in 1994 as well as the non-availability 
of the protective vaccine. With increasing knowledge 
of the usefulness of the vaccine vis a vis the 
consequences of lack of protection, acceptability of 
the vaccination programme by the staff and the 
determination of the hospital administration to 
protect its staff against the virus could be 
responsible for the rise in the number of the 
participants over the study period. The downward 
trend in the number of the participants from 1999 to 
2001 could be secondary to the coverage of greater 
proportion of the staff particularly in 1999 with only 
new entries being added thereafter although there 
may be low drive of the HCWs towards their being 
vaccinated against HBV. Furthermore, the low 
participation of subjects above 40 years of age could 
be due to the presence of more staff in the younger 
age groups however the knowledge that the 
sequalae of the infection is predominantly in the 2nd 
to 5th decades of life12 among Nigerians could be the 
motivating force inspiring the greater participation 
of the younger adult population in comparison to 
the older adults. 
The distribution of the different proportions of the 
HCWs involved the programme is not unexpected as 
it follows previous report [4]. It shows the awareness 
the HCWs of their risk status for the infection [1, 6-
10]. The participation of student HCWs in the 
programme supports the need for their 
immunization against HBV since they are also at 
high risk of contacting the infection [6, 13]. The 
presence of incomplete data on a significant 
proportion of the workers is unacceptable and it 
suggests an improvement is needed in the collection 
of data from the vaccinees.  Furthermore, the 
coverage of the immunization programme is very 
low among the total population of the HCWs at 
UCH, Ibadan, hence there need for ensuring 100% 
coverage of the workers. 
 The completion rate of a three-dose accelerated 
HBV vaccine schedule among the HCWs studied, 
falls below the report among similar groups of 
subjects in the USA [4, 15]. Efforts should be made to 
improve compliance to the vaccination schedule 
since receipt of only one dose confers no protection. 
The receipt of two doses may offer only some 
protection (61.4%) [16] but it is lesser than what 
occurs with the receipt of three doses (80-95%) [8]. 
The supervision of the programme in 1999 was 
associated with the high participatory rate of the 
workers for the receipt of three doses of vaccine 
while the converse could be responsible for the poor 
compliance recorded in the other years. Hence, this 
study has demonstrated the positive role of a 
supervisory vaccination prograrmme [15] actively 
financed and purposely carried out by the 
management of a tertiary Nigerian heath institution 
at ensuring a high compliance rate from the 
vaccinees with consequent development of high 
protection rate against the infection.  
However, a fourth dose at 6th or 12 month post 1st 
dose will confer higher anti-HBs titre with protection 
beyond 12 months (offered by 3 dose regimen) to 5-8 
years when a booster dose will be required [8, 17]. It 
is obvious from this study that no worker had a 
fourth or booster dose post the 1st dose. The booster 
dose at 5 year is advocated for HCWs in order to 





ensure their safety for patient care [8]. It is advocated 
that all workers should be educated on the 
importance of the dosing schedule as well as their 
compliance to completion of the vaccination 
programme. Furthermore, efforts should be made to 
immunize all the workers as this ensures their 
protection against the virus than when not 
immunized [18].  The prescreening rate of the 
workers for HBV prior vaccination from 0% in 1994 
and 1995 to 100% in 1999 to 2001 is commendable 
because the assay is necessary in Nigeria, a hyper 
endemic area for HBV [6,13] and particularly among 
HCWs who have high rate of HBV [5,18,19]. 
However, the prescreening for HBV prior to 
vaccination is a good course of action which needs to 
be maintained as it helps to determine the status of 
the worker in an area of HBV hyper-endemicity and 
thus prevents a false protection for an already 
infected worker.  
The prescreening for both HBsAg and anti-HBc 
carried out in 1999 follows acceptable norm [2, 18, 
19] especially in HBV hyper-endemic areas [1]. The 
use of either Engerix – or Genevac –B vaccine at any 
of the dose of the HBV vaccination schedule 
observed from the study follows previous reports [8-
10, 20]; hence any available recombinant DNA 
technology type of HBV vaccines could be 
administered. This will enhance compliance of the 
subjects to the vaccination schedule.  
Inspite of the efforts made at vaccinating the HCWs 
against HBV, the absence of assay of anti-HBs titre 
after the receipt of third dose of the vaccine left the 
vaccination programme uncompleted since the 
responses of the vaccinated subjects were 
undetermined and thus their immuned status are 
uncertain.   
In conclusion, vaccination of HCWs has been 
implemented in a Nigerian tertiary hospital and 
efforts should be made and sustained at overcoming 
the shortcomings and obstacles at ensuring a full 
completion rate of a four-dose accelerated HBV 
vaccine schedule regimen (0, 1, 2 and 12 months), 
100% prescreening of workers for HBV infection, 
vaccination of all non-immuned and HBsAg sero-
negative workers as well as proper collection of data 
from all vaccinees. In addition, all categories of 
workers should be offered facilities for another form 
of accelerated HBV vaccine schedule (0, 1, 3 weeks 
12 months) if they have to travel away within one 
month of being vaccinated and post vaccination anti-
HBs titre for the determination of the protection 
level as well as administration of booster dose. 
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